Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography

NCT05065073 is registered in ClinicalTrials.gov with Minneapolis Heart Institute Foundation as lead sponsor.

NCT NCT05065073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05065073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
Lead sponsor
Minneapolis Heart Institute Foundation
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2021
Completion date
June 30, 2023
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast media reaction, coronary artery disease